作者
Aleksandra Romaniuk, Anna Paszel-Jaworska, Ewa Totoń, Natalia Lisiak, Hanna Hołysz, Anna Królak, Sylwia Grodecka-Gazdecka, Błażej Rubiś
发表日期
2019/2/1
来源
Molecular biology reports
卷号
46
页码范围
1401-1411
出版商
Springer Netherlands
简介
Telomerase is perceived as an immortality enzyme that enables passing the Hayflick limit. Its main function is telomere restoration but only in a limited group of cells, including cancer cells. Since it is found in a vast majority of cancer cells, it became a natural target for cancer therapy. However, it has much more functions than just altering the metabolism of telomeres—it also reveals numerous so-called non-canonical functions. Thus, a question arises whether it is always beneficial to turn it off when planning a cancer strategy and considering potential side effects? The purpose of this review is to discuss some of the recent discoveries about telomere-independent functions of telomerase in the context of cancer therapy and potential side effects.
引用总数
2019202020212022202320241091481511
学术搜索中的文章
A Romaniuk, A Paszel-Jaworska, E Totoń, N Lisiak… - Molecular biology reports, 2019